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We studied the frequency of diabetic ketoacidosis (DKA) in children at diagnosis of type 1 diabe-
tes (T1D) in a region where newborn infants have since 1995 been recruited for genetic screen-
ing for human leukocyte antigen (HLA)-conferred disease susceptibility and prospective follow
up. The aim was to study whether participation in newborn screening and follow up affected the
frequency of DKA, and to follow the time trends in DKA frequency. We first included children
born in Oulu University Hospital since 1995 when the prospective studies have been ongoing
and diagnosed with T1D <15 years by 2015 (study cohort 1, n = 517). Secondly, we included all
children diagnosed with T1D <15 years in this center during 2002-2014 (study cohort
2, n = 579). Children who had an increased genetic risk for T1D and participated in prospective
follow up had low frequency of DKA at diagnosis (5.0%). DKA was present in 22.7% of patients
not screened for genetic risk, 26.7% of those who were screened but had not an increased risk
and 23.4% of children with increased genetic risk but who were not followed up. In study cohort
2 the overall frequency of DKA was 18.5% (13.0% in children <5 years, 14.0% in children 5-10
years and 28.6% in children ≥10 years at diagnosis; P<.001). In children <2 years the frequency
of DKA was 17.1%. Participation in prospective follow-up studies reduces the frequency of DKA
in children at diagnosis of T1D, but genetic screening alone does not decrease DKA risk.
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1 | INTRODUCTION
Diabetic ketoacidosis (DKA), a metabolic derangement characterized
by the triad of hyperglycemia, acidosis, and ketosis, is commonly
observed at diagnosis of type 1 diabetes (T1D) in children. The fre-
quency varies between 15% and 80% and correlates inversely with
the background incidence of T1D.1–3 In some studies, DKA at diagno-
sis seems to have decreased4,5 while other studies have reported sta-
ble or even increased frequencies of DKA.6–8
An alarming fact is that DKA is most common in the youngest
children at diagnosis of T1D. Children younger than 5 years and
especially children under 2 years of age at diagnosis are at a high risk
for DKA.7,9,10 Although young children have been reported to have a
short duration of symptoms before the diagnosis of T1D, a delay in
diagnosis due to various reasons, for example concurrent infections
and misdiagnosis, may also occur.11 Education about the initial symp-
toms of T1D and importance of early diagnosis may be challenging in
the population level, but there are some published reports of the
effectiveness of medical information on the frequency of DKA. For
instance an 8-year campaign focusing on medical information on the
early symptoms of diabetes reduced the incidence of DKA in children
with newly diagnosed T1D in Italy.12 Similarly, a 2-year intervention
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period with education regarding T1D offered at child care centers,
schools, and doctors’ offices resulted in a decreased frequency of
DKA at initial diagnosis.13 It is also known that children with a first-
degree relative (FDR) (mother, father and siblings) with T1D have a
reduced risk for DKA at diagnosis.14
Several prospective studies have followed from birth children at
increased genetic risk of T1D. These studies provide the risk informa-
tion to all families participating in newborn genetic screening. Inten-
sive follow up of children with increased disease risk may increase
the awareness of symptoms thus resulting in an earlier diagnosis and
prevention of DKA. In the Diabetes Autoimmunity Study in the
Young (DAISY) children screened for genetic risk and observed regu-
larly had a less severe onset of the disease characterized by a
reduced hospitalization rate and lower mean HbA1c at onset.15 The
German BABYDIAB study reported that the children with an affected
FDR and regular follow up had lower HbA1c and a reduced fre-
quency of DKA (pH < 7.30) at diagnosis as compared with commu-
nity controls, 3.3% vs 29.1%, P < .001.16 Young children (<2 and
<5 years) participating in the international TEDDY (The Environmen-
tal Determinants of Diabetes in the Young) study had a significantly
lower rate of DKA at diagnosis of T1D when compared with data col-
lected during similar periods from studies and registers in all TEDDY-
participating countries.17 In the first 100 children observed in the
TEDDY study and diagnosed with T1D (age: 0.69-6.27 years) the risk
of DKA was low (8%). In addition, 36% of these children had no
symptoms of diabetes before diagnosis.18
The aim of the current study was to determine the risk of DKA
in children at diagnosis of T1D in Oulu University Hospital where the
prospective follow-up studies have been going on since 1995 with
the hypothesis that such studies may have a decreasing effect on the
overall risk of DKA in the population. In addition, we wanted to ana-
lyze the frequency of DKA at diagnosis of T1D in this center in 2002
to 2014 to follow our earlier observations, and to compare the risk of
DKA in children with increased genetic risk who did or did not partic-
ipate in the prospective follow up.
2 | METHODS
Our study includes children with newly diagnosed T1D at Oulu Uni-
versity Hospital (Figure 1). For the current analyses we constructed
2 study cohorts in order to address the specific study questions.
Majority of the children (n = 485) were included in both cohorts.
Study cohort 1 comprised the children who were diagnosed with
T1D under the age of 15 years by December 2014 and who were
born in 1995-2012, during the time period when 2 prospective T1D
studies recruited all newborn infants in Oulu University Hospital for
human leukocyte antigen (HLA) screening and subsequent follow
up. The Finnish T1D Prediction and Prevention (DIPP) Study in Fin-
land is based on screening for HLA-DR/DQ-conferred susceptibility
to T1D in infants born in the university hospitals of Turku, Oulu and
Tampere.19 The Environmental Determinants of Diabetes in the
Young (TEDDY) study is an international, longitudinal, observational
investigation with a goal to identify environmental triggers of T1D in
children genetically at risk.20 With the DIPP and TEDDY studies,
information of T1D, and screening for disease associated risk genes
were offered to all families with a newborn baby. The infants with the
defined HLA-DR/DQ genotypes associated with an increased risk for
T1D were invited to regular clinical, immunological, and metabolic
follow-up, in order to detect possible signs of islet autoimmunity associ-
ated with an increased risk of the disease.21,22 The DIPP study started
to recruit newborns for HLA screening in Oulu in September 1995, and
the recruitment is still ongoing. The TEDDY Study screened newborn
infants during 2004-2010 in Oulu. In both the DIPP and TEDDY stud-
ies, HLA-DR/DQ-conferred genetic risk for T1D was analyzed from
cord blood.19,23 As the genetic inclusion criteria for TEDDY and DIPP
were only partly overlapping there were children with an increased dis-
ease risk not eligible to TEDDY who were recruited to DIPP in 2004 to
2010. The group of subjects with prospective follow up included chil-
dren who had completed at least 1 visit to the study center as well as
children who had participated regularly in the follow-up study until their
diagnosis. During the first study center visit, a lot of information on
T1D and preclinical diabetes was given to the family. In addition, if the
child seroconverted to positivity for islet autoantibodies, a more intense
follow up with further information and possibilities for discussions with
the study personnel was organized. For the purposes of the current
study the information on the participation in the prospective follow up
was generated from the Oulu University Hospital patient registry at the
time of diagnosis.
In study cohort 1 the total number of children was 517, mean
age at diagnosis was 6.30 years (range: 0.52-14.87 years). Of these
children 227 of 517 (43.9%) were younger than 5 years, 194 of
517 (37.5%) were 5.0-9.99 years and 96 of 517 (18.6%) were 10.0-
14.99 years at diagnosis.
Study cohort 2 comprised all the children who had been diagnosed
with T1D under the age of 15 years in Oulu University Hospital during
2002 to 2014 (n = 579, boys 341, 58.9%). We have earlier studied the
frequency of DKA at diagnosis of T1D in 1982 to 2001 in Oulu Univer-
sity Hospital,4 and found that DKA was decreasing during this 20-year
period. Now we wanted to follow whether a further decrease since
2001 had occurred. The children in study cohort 2 were born in 1987-
2012. Their mean age at diagnosis was 7.53 years (range 0.52-
14.99 years). There were 185 of 579 (32.0 %) children aged 0-
4.99 years, 205 of 579 (35.4%) children aged 5.00-9.99 years and
189 of 579 (32.6 %) children 10.00-14.99 years old at diagnosis. A total
of 41 of 579 (7.1%) children were under 2 years of age at diagnosis.
The information on the duration of the symptoms before diagno-
sis was received from the patient registry and the estimated weight
loss (%) was assessed based on the Finnish growth charts by weight
at diagnosis and expected weight by height.24 Standard laboratory
methods were used to analyze venous pH, HbA1c, and
β-hydroxybutyrate values in the hospital laboratory and the informa-
tion on the values were collected from the hospital register. DKA was
defined as a venous pH <7.30 and considered severe if pH was
<7.10. The study was approved by the local ethics committee.
2.1 | Statistical analyses
The frequency of DKA was analyzed with 2 approaches by categoriz-
ing the children into the 2 study cohorts described above. In study
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cohort 2 the frequency of DKA at diagnosis was compared in differ-
ent age groups (<2 years, 0-4.99, 5.0-9.99, and 10.0-14.99 years at
diagnosis), by gender, and in 3 time periods (1/2002-4/2006,
5/2006-8/2010, and 9/2010-12/2014) to identify the possible secu-
lar change in the frequency of DKA. In study cohort 1, the frequency
of DKA was analyzed in the groups defined based on participation in
the HLA screening and follow up in the prospective diabetes studies
(Figure 1).
Data analysis was performed by using SPSS for Windows statisti-
cal software (version 20.0; SPSS, Chicago, Illinois). Student’s 2-tailed
t test for independent samples was used for pair-wise comparisons
when comparing variables with normal distributions. The Mann-
Whitney U test was applied for unequally distributed variables. Distri-
butions were analyzed by cross-tabulation and χ2 statistics. Univari-
ate analysis with age-standardization was used while comparing
continued variables when analyzing groups based on participation of
the screening and follow up. When analyzing the 3 age groups, 1-
way analysis of variance was used for variables with normal distribu-
tions and the Kruskal-Wallis test for unequally distributed variables.
A 2-tailed P value of <.05 was considered to indicate statistical
significance.
3 | RESULTS
In study cohort 1 representing 517 children born since September 1995
the overall frequency of DKA was 17.6% and that of severe DKA 3.5%
at diagnosis of T1D. No difference was seen in the frequency of DKA
between females and males (19.4% vs 16.6%, respectively P = .408).
Similarly, the frequency of severe DKA was not significantly different
between the sexes (females 5.1% vs males 2.4%; P = .099). In total
288 of 517 children (55.7%) had been screened from cord blood for
HLA-conferred risk for T1D. The comparison of the children based on
participation in the screening for HLA-conferred disease risk and the
prospective follow up is presented in Table 1. The frequency of DKA
was the lowest (5.0%) in children who had an increased HLA-associated
genetic risk and were followed in a prospective diabetes study when
compared with children with no HLA screening and children with HLA
screening but no follow-up (P < .001). Severe DKA was seen in only
1/159 (0.6% of the children) who participated in both genetic screening
and follow-up. This was an 11-year-old boy whose family had taken part
only in the first information visit to the DIPP center at the age of
3 months. When comparing the age groups and participation in the
prospective follow up, we found that children diagnosed at the age of
Study cohort 1 
Inclusion criteria: 
1. children born in 1995-2012 (ongoing 
recruitment for prospective studies) 
2. diagnosis of T1D by the end of 2014 
N=517
No HLA screening 
N=229 
All children with newly-diagnosed T1D <15 years of age at Oulu University Hospital in 1982-2014 
N=1164 
Frequency of DKA in 
subjects diagnosed in 



















Study cohort 2 
Inclusion criteria: 
1. diagnosis of T1D in 2002-2014 
N=579
Children <5 years 
N=185 
Children 5-9 years 
N=205 
Children 10-14 years 
N=189 
FIGURE 1 The flow chart represents the study cohort 1 and 2. All children living in the catchment area of Oulu University Hospital and who
were diagnosed with T1D under the age of 15 years in 1982 to 2014 were registered (n = 1164). Frequency of DKA in children diagnosed in
1982 to 2001 (n = 585) was reported earlier.4 In the study cohort 2 (n = 579) the frequency of DKA in children diagnosed thereafter, in 2002 to
2014, was analyzed to follow the trend in the frequency of DKA at diagnosis in various age groups. In the study cohort 1 (n = 517) we included
children who were born in 1995 to 2012, when recruitment for the prospective DIPP and TEDDY studies was ongoing in Oulu University
Hospital, and who were diagnosed with T1D by the end of 2014. The study cohort 1 was divided into 4 subgroups based on whether the
children had or had not been (i) screened for human leukocyte antigen (HLA) (n = 288 and n = 229, respectively), (ii) had no increased HLA-
conferred risk (n = 81), (iii) had an increased HLA-conferred risk but did not participate in the follow up (n = 48), or (iv) had an increased HLA-
conferred risk and participated in the follow up (n = 159). Note that the study cohort 1 and 2 overlap with 485 children belonging to both
groups
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10-14 years had participated in a prospective diabetes study less fre-
quently (18/96, 18.8%) than children who were 5-9 years old (61/194,
31.4%) or younger than 5 years old at diagnosis (80/227,
35.2%; P = .015).
In study cohort 2 that included all the 579 children diagnosed with
T1D during 2002 to 2014 the overall frequency of DKA was 18.5% and
the frequency of severe DKA 3.5% at presentation. The median pH was
7.37 (interquartile range [IQR] 7.32-7.40), the median blood
β-hydroxybutyrate 1.2 mmol/L (IQR 0.3-4.0) and the median blood
HbA1c 91.3 mmol/mol (IQR 72.7-113.1), 10.5% (IQR 8.8-12.5). The
median duration of symptoms before diagnosis was 14.0 days (IQR 4.0-
21.0). We found no differences in the frequency of DKA or severe DKA
between females and males (20.4% vs 17.2%, P = .322 and 5.1% vs
2.4%, P = .079; respectively). When comparing children younger than
2 years at diagnosis (n = 41) with older children (n = 538), the frequency
of DKA and severe DKA was observed to be almost equal (DKA occurred
in 17.1% of children <2 years old vs 18.6% in older children, P = .807
and severe DKA occurred in 2.4% of children <2 years vs 3.6% in older
children, P = .703). The comparison of the 3 age groups (0-4.9 years, 5.0-
9.9 years, and 10.0-14.9 years) is presented in Table 2. The frequency of
DKA was found to increase by age at diagnosis (13.0% in children under
5 years of age, 14.0% in children 5-9 years of age, and 28.6% in 10-14
-year-old children; P < .001). Similarly, severe DKA was seen most fre-
quently in the oldest children (6.9% vs 2.2% in children <5 years and
1.5% in children 5-9 years, P = .008). The frequency of DKA did not
change over the 3 time periods (20.8% in 1/2002-4/2006, 17.4% in
5/2006-8/2010, and 17.6% in 9/2010-12/2014, P = .638).
4 | DISCUSSION
We report the frequency of DKA at the clinical diagnosis of T1D
from a single clinical center in Finland, which treats all children with
newly diagnosed T1D who live in the catchment area. Our center has
recruited newborn infants and their families for more than 20 years
for prospective clinical follow-up studies where genetic disease risk is
assessed from cord blood and regular follow up is offered to the
families with a child carrying a genotype associated with an increased
disease risk. We confirm that participation in a preclinical follow-up
study reduces the frequency of DKA at diagnosis. However, genetic
screening alone was not associated with a decreased DKA risk.
While analyzing the children born since 1995, when the DIPP
study started in Oulu University Hospital, the DKA risk was found to
be the lowest (5%) in the group of children who carried HLA-DR/DQ
conferred susceptibility to T1D and were observed prospectively in a
follow-up study. Our observation of the low frequency of DKA at the
time of diagnosis of T1D is in line with earlier studies on children tak-
ing part in preclinical follow up.15,16,18 However, in children with
increased genetic risk but not participating in a follow-up study or in
children without risk genotypes and thus not invited for follow up,
the risk of DKA was similar in comparison with the total group of
children born since September 1995. Thereby, it seems that the iden-
tification of an increased risk at newborn screening does not
decrease the frequency of DKA at clinical diagnosis. Indeed, the fre-
quency of DKA was the highest in children with no increased genetic
risk (26.3%), that is higher than in children who were not screened at
all. This is worrisome, because some families may mistakenly think
that their children with no increased genetic risk are protected and
will never develop T1D and may therefore not become concerned in
response to emerging symptoms.
The overall frequency of DKA at diagnosis of T1D in children in
Finland has been relatively low since the 1980s.25 In our earlier
study, the DKA frequency was 22.4% in 1982 to 1991 and 15.2% in
1992 to 2001 in Oulu University Hospital. In the most recent time
period in 2002 to 2014 in the current study, the frequency of DKA
was 18.5%. The mean age at diagnosis has become younger, being
TABLE 1 Diagnostic characteristics of children born in 1995 to 2012 and diagnosed with type 1 diabetes in 1997 to 2014 (cohort 1)










prospective follow up P-value
Number of children (N = 517) 229 81 48 159
Boys/girls 133/96 48/33 28/20 89/70 .961
Mean age at diagnosis (y, 95% CI) 6.75 (6.26-7.23) 6.92 (6.15-7.70) 5.50 (4.60-6.40) 5.60 (5.01-6.12) .002
Duration of symptoms before diagnosis, days
(95% CI)
14.9 (13.0-16.8) 17.7 (14.3-21.1) 13.7 (10.0-17.3) 5.7 (4.4-7.1) <.001
Estimated weight loss, % (95% CI) 7.1 (6.3-7.9) 7.8 (6.7-8.8) 6.1 (4.3-7.9) 2.9 (2.3-3.5) <.001
pH (95% CI) 7.34 (7.32-7.36) 7.31 (7.29-7.35) 7.35 (7.32-7.38) 7.39 (7.38-7.39) <.001
Blood β-hydroxybutyrate, mmol/l (95% CI) 2.66 (2.32-2.99) 3.13 (2.51-3.74) 2.46 (1.62-3.29) 0.77 (0.55-0.99) <.001
Blood HbA1c, % (95% CI) 10.77 (10.46-11.08) 11.39 (10.75-12.02) 10.42 (9.68-11.17) 8.52 (8.21-8.84) <.001
Blood HbA1c, mmol/mol (95% CI) 94.2 (90.8-97.6) 101.0 (94.0-107.9) 90.4 (82.3-98.6) 69.6 (66.2-73.1) <.001
DKA, pH < 7.30, % (95% CI) 22.7 (17.2-28.2) 26.3 (16.7-35.9) 23.4 (11.3-35.5) 5.0 (1.6-8.4) <.001
Severe DKA, pH < 7.10, % (95% CI) 4.4 (1.7-7.1) 6.3 (1.0-11.6) 4.3 (0-10.1) 0.6 (0-1.8) .098
Abbreviations: CI, confidence interval; DKA, diabetic ketoacidosis; HLA, human leukocyte antigen.
The subjects are grouped on the basis of cord blood screening for disease-associated HLA genotypes and participation in a prospective follow-up study.
Data are expressed as frequencies and means (95% CI). Distributions were analyzed by cross-tabulation and χ2 statistics. Univariate analysis with age-
standardization was used while comparing continuous variables. P value of <.05 was considered to indicate statistical significance and presents the differ-
ences between the 4 groups based on the screening and participation of the prospective follow-up studies.
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7.5 years in the current study cohort vs 8.3 years in children diag-
nosed in 1982 to 2001.4 Low frequencies of DKA at diagnosis
(12.8%-16%) have also been published from Sweden.26,27 In many
other countries the frequency of DKA at diagnosis vary a lot, and
very high frequencies up to 80% at diagnosis have been reported.2
T1D is a well-known disease in Finland among both the public and
the healthcare staff, because the incidence of T1D is the highest in
the world. The awareness of the disease and its symptoms leads
likely to earlier diagnosis. This may also limit generalization of the
present results to other countries. We did not observe further decline
in the overall frequency of DKA, when comparing the 3 time periods
within the latest 13-year period (2002-2014). It is possible that the
frequency of DKA at the time of diagnosis has achieved such a low
level among the Finnish children that it does not decrease further
without extra efforts.
The most positive result was the remarkably decreased DKA fre-
quency seen in the very young children under the age of 2 years at
diagnosis. In the Finnish nationwide study in 1986 to 1989, the fre-
quency of DKA among such children was 53.3%,9 and in our earlier
analysis the frequency in this age group was 50.0% in 1982 to 1991
and 39.1% in 1992 to 2001 in Oulu University Hospital.4 In the
whole of Finland in 2002 to 2005, the frequency of DKA in the
youngest children at diagnosis was still 30.1%.28 In the current study,
the frequency of DKA in the children younger than 2 years of age
was clearly lower, 17.5%, and did not differ from the DKA frequency
in older children. The finding is exceptional because high frequencies
of DKA (53%-69%) are still reported in this very young age group.6,7
Our observation shows that the ongoing prospective studies have a
significant effect on the awareness among the families and healthcare
personnel of this potentially life-threatening disease.
When comparing the frequency of DKA at diagnosis in the differ-
ent age groups we found the frequency to be the lowest (13%)
among children under 5 years age at diagnosis. An appreciable
change in DKA frequency has occurred in this age group in Finland.
In the Finnish nationwide study conducted in 1986 to 1989, the fre-
quency of DKA in this age group was 22.1% at diagnosis9 and in our
earlier study, it was 32.1% in 1982 to 1991 and 17.7% in 1992 to
2001 in Oulu University Hospital.4 According to the data from the
Finnish Pediatric Diabetes Register during 2002 to 2005, the fre-
quency of DKA in this age group was 16.5%.28 The current low fre-
quency of DKA in children diagnosed under 5 years of age in the
Finnish population is similar to that observed in the international
TEDDY study (13.1%).17 Again, our finding may be the result of the
increasing awareness of T1D in families with young children because
of the ongoing longitudinal diabetes studies in our country. It is also
noteworthy that in many developed countries the frequency of DKA
is still inversely associated with age at diagnosis.7,29,30
The most severe disquietude concerns the high frequency of
DKA (28.6%) in children aged 10 to 14 years. In the Finnish Pediatric
Diabetes Register the frequency of DKA in this age group was 26.2%
at clinical diagnosis.28 It appears that unfortunately the frequency of
DKA is not decreasing among teenagers in Finland. The underlying
reasons are not apparent, and many factors may have an impact. Dur-
ing recent years the school healthcare has changed considerably, and
the children cannot meet the school health nurse as often as earlier.
Many families have been broken up, and the children may live in
more than 1 family. The parents may not oversee their adolescents as
carefully as earlier, because the teenagers often take care of them-
selves quite well. In addition, the adolescents may have difficulties to
speak with their parents or other adults about their personal health
problems. In the future, it would probably be worthwhile to offer dia-
betes information to adolescents for instance at schools to prevent
DKA in this age group.
A limitation of the study is the lack of data on the socioeconomic
status of the children and their families preventing analysis of the
possible effect of this factor on DKA. However, the parents of the
children participating in the prospective follow-up studies may be
more conscious and active than the parents not participating. The
strength of this study is the fact that nearly all children are born in
public hospitals in Finland, and all children diagnosed with T1D are
treated in these hospitals. Thus the families in this study represent
the general population.
TABLE 2 Comparison of the 3 age groups of children diagnosed with type 1 diabetes during 2002 to 2014 in Oulu University Hospital, Finland
(cohort 2)
Age at clinical diagnosis of type 1 diabetes
cf <5.0 y 5.0-9.9 y 10.0-14.9 y P-value
Number of children 185 205 189
Boys/girls 114/71 112/93 115/74 .301
Duration of symptoms before diagnosis, days (95% CI) 11.4 (9.5-13.2) 14.3 (11.7-16.8) 19.4 (16.1-22.8) <.001
Estimated weight loss, % (95% CI) 4.6 (3.9-5.2) 6.3 (5.5-7.1) 8.3 (7.4-9.3) <.001
pH (95% CI) 7.37 (7.36-7.38) 7.36 (7.35-7.37) 7.32 (7.29-7.33) <.001
Blood β-hydroxybutyrate, mmol/l (95% CI) 1.90 (1.55-2.24) 1.99 (1.67-2.31) 2.48 (2.09-2.86) .001
Blood HbA1c, % (95% CI) 9.58 (9.27-9.90) 10.37 (10.00-10.75) 12.00 (11.48-12.53) <.001
Blood HbA1c, mmol/mol (95% CI) 81.2 (77.8-84.7) 89.9 (85.8-93.9) 107.7 (101.9-113.4) <.001
DKA (pH < 7.30), % (95% CI) 13.0 (8.1-17.8) 14.0 (9.2-18.2) 28.6 (22.2-35.0) <.001
Severe DKA (pH < 7.10), % (95% CI) 2.2 (0.1-4.3) 1.5 (0-3.1) 6.9 (3.3-10.2) .008
Abbreviations: CI, confidence interval; DKA, diabetic ketoacidosis.
Data are expressed as frequencies and means (95% CI). Distributions were analyzed by cross-tabulation and χ2 statistics. One-way analysis of variance
was used for variables with normal distributions and the Kruskal-Wallis test for unequally distributed variables. P value of <.05 was considered to indicate
statistical significance and presents the differences between the 3 age groups.
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In conclusion, participation in the cord blood screening to detect
increased HLA-conferred risk for T1D without any follow up did not
have any effect on the frequency of DKA at diagnosis of T1D.
Instead, children who had increased genetic susceptibility for T1D
and participated in prospective follow-up studies had very infre-
quently DKA at diagnosis. Overall, during 2002 to 2014 the fre-
quency of DKA at diagnosis of T1D was low among children aged
below 10 years, and particularly in those under 2 years in Finland in
the region where prospective birth cohort studies aimed at prediction
and prevention of T1D are ongoing. In the future, more attention
should be paid to adolescents to make earlier diagnosis of T1D and
prevent DKA at disease presentation.
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